News
Experts Question Routine Mammograms in Elderly
Doctors should focus on life expectancy when deciding whether to order mammograms for their oldest female patients, since the harms of screening likely outweigh the benefits unless women are expected to live at least another decade, according to a review of the scientific literature by experts at
Mechanical Forces Driving Breast Cancer Lead to Key Molecular Discovery
The stiffening of breast tissue in breast-cancer development points to a new way to distinguish a type of breast cancer with a poor prognosis from a related, but often less deadly type, UC San Francisco researchers have found in a new study. The findings, published online March 16 in Nature Medicine
Acclaimed British Scientist Is Named Director of the UCSF Helen Diller Family Comprehensive Cancer Center
One of the world’s preeminent cancer scientists, Alan Ashworth, PhD, FRS, has been appointed the new director of the UCSF Helen Diller Family Comprehensive Cancer Center. Ashworth is chief executive of The Institute of Cancer Research, London, one of the world’s most influential cancer research
Molecular Biologist Wins European Prize for Women Innovators
Laura van 't Veer, PhD, was honored this week as one of the top female scientific innovators in Europe. The European Union Prize for Women Innovators recognizes women who have combined their scientific excellence with a head for business to set up innovative enterprises. Van 't Veer was one of three
E-Cigarettes: Gateway to Nicotine Addiction for U.S. Teens, Says UCSF Study
E-cigarettes, promoted as a way to quit regular cigarettes, may actually be a new route to conventional smoking and nicotine addiction for teenagers, according to a new UC San Francisco study. In the first analysis of the relationship between e-cigarette use and smoking among adolescents in the
Key Pancreatic Cancer Defect Is Identified by UCSF Researchers
Pancreatic cancer, compared to other types of leading cancer killers, is detected later and does not respond well to either new or established drugs. Now a new UC San Francisco study has shed light on the origins of one type of deadly pancreatic cancer. In a study published online February 23, 2014
CTSI Spotlight: Joel Palefsky
Joel Palefsky, MD, is the director of the Clinical and Translational Research Fellowship Program (CTRFP) at CTSI. Note: Dr. Palefsky was recently awarded an $89 million grant from the National Cancer Institute for a major investigation of anal cancer. How long have you worked at UCSF? I’ve been at